rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0013089,
umls-concept:C0014245,
umls-concept:C0023828,
umls-concept:C0205223,
umls-concept:C0348011,
umls-concept:C0439611,
umls-concept:C0458421,
umls-concept:C0684224,
umls-concept:C0729595,
umls-concept:C1705822
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-10-6
|
pubmed:abstractText |
Liposome encapsulated doxorubicin administered to the pelvic lymph nodes might be effective against pelvic node metastasis. We determined whether the drug can be delivered to the nodes via the bladder wall.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-5347
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
157
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1652-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9112498-Aged,
pubmed-meshheading:9112498-Aged, 80 and over,
pubmed-meshheading:9112498-Doxorubicin,
pubmed-meshheading:9112498-Drug Carriers,
pubmed-meshheading:9112498-Female,
pubmed-meshheading:9112498-Humans,
pubmed-meshheading:9112498-Injections,
pubmed-meshheading:9112498-Liposomes,
pubmed-meshheading:9112498-Lymph Nodes,
pubmed-meshheading:9112498-Male,
pubmed-meshheading:9112498-Middle Aged,
pubmed-meshheading:9112498-Pelvis,
pubmed-meshheading:9112498-Urinary Bladder Neoplasms
|
pubmed:year |
1997
|
pubmed:articleTitle |
Liposome encapsulated doxorubicin transfer to the pelvic lymph nodes by endoscopic administration into the bladder wall: a preliminary report.
|
pubmed:affiliation |
Department of Urology, Shinshu University School of Medicine, Matsumoto, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|